首页> 外文期刊>International journal of endocrinology >SLC22A1 rs622342 Polymorphism Predicts Insulin Resistance Improvement in Patients with Type 2 Diabetes Mellitus Treated with Metformin: A Cross-Sectional Study
【24h】

SLC22A1 rs622342 Polymorphism Predicts Insulin Resistance Improvement in Patients with Type 2 Diabetes Mellitus Treated with Metformin: A Cross-Sectional Study

机译:SLC22A1 RS622342多态性预测二甲双胍治疗2型糖尿病患者的胰岛素抵抗力:横截面研究

获取原文
           

摘要

Background. Metformin is the most widely used oral antidiabetic agent and can reduce insulin resistance (IR) effectively. Organic cation transporter 1 (encoded by SLC22A1) is responsible for the transport of metformin, and ataxia-telangiectasia-mutated (ATM) is a gene relating to the DNA repair and cell cycle control. The aim of this study was to evaluate if the genetic variants in SLC22A1 rs622342 and ATM rs11212617 could be effective predictors of islet function improvement in patients with type 2 diabetes mellitus (T2DM) on metformin treatment. Methods. This cross-sectional study included 111 patients with T2DM treated with metformin. Genotyping was performed by the dideoxy chain-termination method. The homeostatic indexes of IR (HOMA-IR) and beta-cell function (HOMA-BCF) were determined according to the homeostasis model assessment. Results. Fasting plasma glucose (FPG) levels, HbA1c levels, and HOMA-IR were significantly higher in patients with the rs622342 AA genotype than in those with C allele (P0.05). However, these significant differences were not observed between rs11212617 genotype groups. Further data analysis revealed that the association between the rs622342 polymorphism and HOMA-IR was gender related, and so was rs11212617 polymorphism and HOMA-BCF. HOMA-IR was significantly higher in males with rs622342 AA genotype than in those with C allele (P=0.021), and HOMA-BCF value was significantly higher in females carrying rs11212617 CC genotype than in those with A allele (P=0.038). The common logarithm (Lg10) of HOMA-BCF was positively correlated with the reciprocal of HbA1c (r?=?0.629, P0.001) and negatively associated with Lg10 FPG (r?=??0.708, P0.001). Conclusions. The variant of rs622342 could be a predictor of insulin sensitivity in patients with T2DM treated with metformin. The association between the rs622342 polymorphism and HOMA-IR and the association between the rs11212617 polymorphism and HOMA-BCF were both gender related.
机译:背景。二甲双胍是最广泛使用的口腔抗糖尿病药剂,可有效降低胰岛素抵抗(IR)。有机阳离子转运蛋白1(由SLC22A1编码)负责二甲双胍的转运,并且Ataxia-Telanciectasia-突变(ATM)是与DNA修复和细胞周期控制有关的基因。本研究的目的是评估SLC22A1 RS622342和ATM RS11212617中的遗传变体是否可以是患有2型糖尿病(T2DM)对二甲双胍治疗的胰岛功能改善的有效预测因子。方法。这种横截面研究包括111例用二甲双胍处理的T2DM患者。基因分型通过双脱氧链终止方法进行。根据稳态模型评估确定IR(HOMA-IR)和β细胞功能(HOMA-BCF)的稳态指标。结果。 RS622342 AA基因型的患者比在C等位基因(P <0.05)中,禁食血浆葡萄糖(FPG)水平,HBA1C水平和HOMA-IR显着更高(P <0.05)。然而,在RS11212617基因型组之间未观察到这些显着差异。进一步的数据分析表明,RS622342多态性与HOMA-IR之间的关联是性别相关的,因此G11212617多态性和HOMA-BCF也是如此。 HOMA-IR含有RS622342 AA基因型显着高于C等位基因(P = 0.021),载体载有RS11212617 CC基因型的女性显着高于等位基因(P = 0.038)。 HOMA-BCF的常见对数(LG10)与HBA1C(Rα= 0.629,P <0.001)的倒数呈正相关,并与LG10 FPG负相关(R?=Δ0.708,P <0.001)。结论。 RS622342的变体可以是用二甲双胍治疗T2DM患者胰岛素敏感性的预测因子。 RS622342多态性与HOMA-IR与HOS11212617多态性和HOMA-BCF之间的关联均与性别有关。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号